New England Research & Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$1.92M |
| 2 |
Lowe's Companies
LOW
|
+$1.92M |
| 3 |
3M
MMM
|
+$1.39M |
| 4 |
Carrier Global
CARR
|
+$1.29M |
| 5 |
CarMax
KMX
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$1.17M |
| 2 |
Novartis
NVS
|
+$1.09M |
| 3 |
Chegg
CHGG
|
+$1.07M |
| 4 |
Teradyne
TER
|
+$976K |
| 5 |
Eli Lilly
LLY
|
+$929K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.77% |
| 2 | Healthcare | 18.64% |
| 3 | Technology | 17.5% |
| 4 | Consumer Staples | 14.2% |
| 5 | Consumer Discretionary | 9.87% |
Similar funds
New England Research & Management's Q4 2020 Portfolio in Review
As of Q4 2020, New England Research & Management held 171 positions worth $162M, up 17% from $138M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
New England Research & Management deployed $10.6M of net new capital in Q4 2020, opening 38 new positions and adding to 27 existing holdings. Its largest new stake was Air Products & Chemicals: 6,825 shares worth $1.86M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Teradyne, an estimated $976K trimmed.
- New England Research & Management's largest Q4 2020 buy was Air Products & Chemicals: 6,825 shares worth $1.86M.
- New England Research & Management added most to 3M in Q4 2020, an estimated $1.39M increase.
- New England Research & Management's biggest Q4 2020 reduction was Teradyne, cutting an estimated $976K.
- New England Research & Management fully exited Leidos in Q4 2020, selling an estimated $1.17M.
- New England Research & Management's ten largest holdings make up 23% of its $162M portfolio in Q4 2020.
- New England Research & Management opened 38 new positions and closed 21 in Q4 2020.
- New England Research & Management's portfolio value rose 17% quarter-over-quarter to $162M.
Based on New England Research & Management's 13F filing for Q4 2020, filed 7 Jan 2021.